A novel hepatitis C virus NS5B polymerase assay of de novo initiated RNA synthesis directed from a heteropolymeric RNA template

Methods in Molecular Biology

Volumn 1030, Issue , 2013, Pages 81-92

  Ferrari, Eric ^a   Huang, Hsueh Cheng ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

De novo RNA synthesis; Elongation; Hepatitis C virus; Heteropolymer RNA template; Initiation; NS5B; Nucleotides; Polymerase inhibitors; RNA dependent RNA polymerase

Indexed keywords

RNA DIRECTED RNA POLYMERASE; VIRUS RNA; ZALCITABINE;

ARTICLE; DRUG SCREENING; ENZYME ASSAY; HEPATITIS C VIRUS NS5B POLYMERASE ASSAY; PRIORITY JOURNAL; RIBONUCLEIC ACID TEMPLATE; RNA STRUCTURE; RNA SYNTHESIS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; ENZYME ACTIVATION; ENZYME ASSAYS; ENZYME INHIBITORS; HEPACIVIRUS; HUMANS; RNA, VIRAL; TEMPLATES, GENETIC; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84880092558     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-484-5_7     Document Type: Article

References (21)

1. Powdrill MH, Bernatchez JA, Götte M (2010) Inhibitors of the hepatitis C virus RNAdependent RNA polymerase NS5B. Viruses 2:2169-2195
2. Beaulieu PL (2009) Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection. Expert Opin Ther Pat 19:145-164
3. Ferrari E, He Z, Palermo RE, Huang H-C (2008) Hepatitis C virus NS5B polymerase exhibits distinct nucleotide requirements for initiation and elongation. J Biol Chem 283:33893-33901
4. Cheng CC, Huang X, Shipps GW Jr, Wang YS, Wyss DF, Soucy KA, Jiang CK, Agrawal S, Ferrari E, He Z, Huang H-C (2010) Pyridine carboxamides: potent palm site inhibitors of HCV NS5B polymerase. ACS Med Chem Lett 1:466-471
5. Anilkumar GN, Lesburg CA, Selyutin O et al (2011) I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles. Bioorg Med Chem Lett 21:5336-5341
6. Chen KX, Lesburg CA, Vibulbhan B et al (2012) A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors. J Med Chem 55:2089-2101
7. Oh JW, Ito T, Lai MM (1999) A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol 73:7694-7702
8. Dhanak D, Duffy KJ, Johnston VK et al (2002) Identifi cation and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 277:38322-38327
9. Beaulieu PL, Bös M, Bousquet Y et al (2004) Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorg Med Chem Lett 14:119-124
10. Behren SE, Tomei L, De Francesco R (1996) Identifi cation and properties of the RNAdependent RNA polymerase of hepatitis C virus. EMBO J 15:12-22
11. Lohmann V, Körner F, Herian U, Bartenschlager R (1997) Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identifi cation of amino acid sequence motifs essential for enzymatic activity. J Virol 71:8416-8428
12. Luo G, Hamatake RK, Mathis DM et al (2000) De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol 74:851-863
13. Zhong W, Uss AS, Ferrari E et al (2000) De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol 74:2017-2022
14. Carroll SS, Sardana V, Yang Z et al (2000) Only a small fraction of purifi ed hepatitis C RNAdependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays. Biochemistry 39:8243-8249
15. Tomei L, Altamura S, Bartholomew L et al (2003) Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNAdependent RNA polymerase. J Virol 77: 13225-13231
16. Howe AY, Bloom J, Baldick CJ et al (2004) Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother 48: 4813-4821
17. Carroll SS, Tomassini JE, Bosserman M et al (2003) Inhibition of hepatitis C virus RNA replication by 2?-modifi ed nucleoside analogs. J Biol Chem 278:11979-11984
18. Lam AM, Murakami E, Espiritu C et al (2010) PSI-7851, a pronucleotide of beta-D-2?-deoxy-2?-fl uoro-2?-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob Agents Chemother 54:3187-3196
19. Liu Y, Jiang WW, Pratt J et al (2006) Mechanistic study of HCV polymerase inhibitors at individual steps of the polymerization reaction. Biochemistry 45:11312-11323
20. Harrus D, Ahmed-El-Sayed N, Simister PC et al (2010) Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis. J Biol Chem 285:32906-32918
21. Ferrari E, Wright-Minogue J, Fang JW et al (1999) Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli . J Virol 73: 1649-1654